Alzheimers brain
Biotech

Roche pays Ionis $60M to license Alzheimer's, Huntington's drugs

Ionis will take the RNA-editing programs through preclinical studies before Roche takes responsibility for human trials and beyond.
James Waldron Sep 27, 2023 8:56am
Gilead

Gilead ends phase 3 leukemia trial early after data disappoint

Sep 27, 2023 7:48am
Emulate

Improving the Drug Development Process with Organ-Chips

Sep 25, 2023 8:00am
Photo of 100 bills overlapping each other in the frame

Pfizer signs $331M deal with Ginkgo for unspecified targets

Sep 27, 2023 9:50am
IPMai

Uncover the Rare Disease Patient Journey

Sep 25, 2023 8:00am
layoff layoffs staff

Galecto lays off 70% in wake of fibrosis drug's phase 2 fail

Sep 27, 2023 7:50am
Medtech News

Philips suppressed concerns years before CPAP recall: ProPublica

Sep 27, 2023 1:58pm

Deep Genomics puts forward AI model for generating RNA therapies

Sep 27, 2023 11:16am

First patient implanted with Onward BCI to restore arm function

Sep 27, 2023 10:57am

Rockley plows ahead in developing noninvasive glucose sensor

Sep 26, 2023 1:11pm